Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NFX.L Stock Summary
Top 10 Correlated ETFs
NFX.L
In the News
NFX.L Financial details
Company Rating
Sell
Market Cap
1.57M
Income
-1.23M
Revenue
0
Book val./share
0.01
Cash/share
0
Dividend
-
Dividend %
-
Employees
3
Optionable
No
Shortable
Yes
Earnings
30 Jun 2024
P/E
-3.27
Forward P/E
-
PEG
-1.04
P/S
-
P/B
0.59
P/C
-
P/FCF
-7.13
Quick Ratio
0.95
Current Ratio
1.42
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-57.89%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-25.98%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-40%
-
-
-
-
SMA20
-4.76%
SMA50
-35.48%
SMA100
-31.03%
Inst Own
-
Inst Trans
-
ROA
-17%
ROE
-17%
ROC
-0.18%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.18-0.44
52W High
-
52W Low
-
RSI
35.74
Rel Volume
0.18
Avg Volume
2.44M
Volume
427.23K
Perf Week
-8.29%
Perf Month
-1.05%
Perf Quarter
-32.86%
Perf Half Y
-31.64%
-
-
-
-
Beta
0.286
-
-
Volatility
0.01%, 0.01%
Prev Close
-1.05%
Price
0.188
Change
-2.39%
NFX.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-09-30
Metric | History | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
Tangible book value per share | -0.01 | 0 | -0.01 | 0 | -0.01 | |
Share holders equity per share | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 19.08M | 13.06M | 5.83M | 0 | 1.87M | |
Enterprise value | 18.61M | 11.39M | 5.37M | -259.26K | 1.67M | |
P/E ratio | -25.23 | -10.42 | -5.26 | 0 | -3.26 | |
Price to sales ratio | 35.67 | 66.81 | 116.7 | 0 | 0 | |
POCF ratio | -26.23 | -15.4 | -4.34 | 0 | -3.42 | |
PFCF ratio | -24.76 | -15.39 | -4.34 | 0 | -3.42 | |
P/B Ratio | 4.02 | 2.3 | 1.23 | 0 | 0.45 | |
PTB ratio | 4.02 | 2.3 | 1.23 | 0 | 0.45 | |
EV to sales | 34.79 | 58.27 | 107.42 | 0 | 0 | |
Enterprise value over EBITDA | -22.25 | -8.9 | -4.35 | 0 | -2.99 | |
EV to operating cash flow | -25.58 | -13.43 | -3.99 | 0.6 | -3.05 | |
EV to free cash flow | -24.15 | -13.42 | -3.99 | 0.6 | -3.05 | |
Earnings yield | -0.04 | -0.1 | -0.19 | 0 | -0.31 | |
Free cash flow yield | -0.04 | -0.06 | -0.23 | 0 | -0.29 | |
Debt to equity | 0.02 | 0 | 0 | 0 | 0 | |
Debt to assets | 0.01 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0.56 | 1.3 | 0.38 | 0 | 0.36 | |
Current ratio | 2.3 | 5.62 | 3.47 | 1.42 | 1.51 | |
Interest coverage | -60.02 | -449.9 | 0 | 0 | 0 | |
Income quality | 0.96 | 0.68 | 1.21 | 0.57 | 0.95 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.01 | 0.03 | 0 | 0 | |
Research and developement to revenue | 0.98 | 1.86 | 11.46 | 0 | 0 | |
Intangibles to total assets | 1.61 | 1.37 | 1.64 | 0.91 | 1.83 | |
Capex to operating cash flow | 0.06 | 0 | 0 | 0 | 0 | |
Capex to revenue | -0.08 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -0.53 | -0.01 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.02 | 0.02 | 0.02 | 0 | 0.01 | |
ROIC | -0.15 | -0.22 | -0.23 | 0 | -0.13 | |
Return on tangible assets | 0.24 | 0.57 | 0.35 | 0 | 0.16 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 449K | 1.5M | 587.11K | 114.25K | 113.76K | |
Tangible asset value | -3.53M | -2.52M | -3.44M | 114.25K | -3.91M | |
Net current asset value | 411.75K | 1.5M | 587.11K | 114.25K | 113.76K | |
Invested capital | 0.02 | 0 | 0 | 0 | 0 | |
Average receivables | 267.43K | 172.87K | 235.74K | 166.47K | 58.14K | |
Average payables | 226.57K | 114.98K | 55.65K | 142.95K | 171.66K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 141.36 | 258.59 | 2.43K | 0 | 0 | |
Days payables outstanding | 143.34 | 331.87 | 116.58 | 0 | 693.01 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 2.58 | 1.41 | 0.15 | 0 | 0 | |
Payables turnover | 2.55 | 1.1 | 3.13 | 0 | 0.53 | |
Inventory turnover | 2934332651.74B | 0 | 0 | 0 | 646495244.95B | |
ROE | -0.16 | -0.22 | -0.23 | 0 | -0.14 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
Metric | History | 2021-09-30 | 2022-03-31 | 2022-09-30 | 2023-03-31 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Tangible book value per share | 0 | -0.01 | 0 | -0.01 | -0.01 | |
Share holders equity per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 7.84M | 5.88M | 2.55K | 2.2M | 1.91M | |
Enterprise value | 6.77M | 5.42M | 2.16K | 1.94M | 1.71M | |
P/E ratio | -4.36 | -2.23 | -1.51 | -1.63 | -2.03 | |
Price to sales ratio | 156.78 | 0 | 0 | 0 | 0 | |
POCF ratio | -13.11 | -7.87 | -7.53 | -23.18K | 52.06 | |
PFCF ratio | -13.11 | -7.87 | -7.53 | -23.18K | 52.06 | |
P/B Ratio | 1.49 | 1.24 | 0.55 | 0.52 | 0.46 | |
PTB ratio | 1.49 | 1.24 | 0.55 | 0.52 | 0.46 | |
EV to sales | 135.34 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -15.72 | -6.75 | -5.33 | -6.07 | -6.5 | |
EV to operating cash flow | -11.32 | -7.24 | -6.38 | -20.45K | 46.54 | |
EV to free cash flow | -11.32 | -7.24 | -6.38 | -20.45K | 46.54 | |
Earnings yield | -0.06 | -0.11 | -0.17 | -0.15 | -0.12 | |
Free cash flow yield | -0.08 | -0.13 | -0.13 | 0 | 0.02 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 2.49 | 0.58 | 0.96 | 0.81 | 0.77 | |
Current ratio | 7.56 | 3.47 | 3.45 | 1.42 | 1.51 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 1.33 | 1.13 | 0.8 | 0.28 | -0.16 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 1.51 | 1.64 | 0.86 | 1.81 | 1.83 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
ROIC | -0.09 | -0.14 | -0.09 | -0.08 | -0.06 | |
Return on tangible assets | 0.16 | 0.21 | -0.65 | 0.09 | 0.06 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 1.08M | 587.11K | 459.61 | 114.25K | 113.76K | |
Tangible asset value | -2.94M | -3.44M | 459.78 | -3.91M | -3.91M | |
Net current asset value | 1.08M | 587.11K | 459.61 | 114.25K | 113.76K | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 314.43 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 735.25 | 1.16K | 0 | 1.34K | 1.09K | |
Days of inventory on hand | -0.54 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.29 | 0 | 0 | 0 | 0 | |
Payables turnover | 0.12 | 0.08 | 0 | 0.07 | 0.08 | |
Inventory turnover | -166.77 | 0 | 0 | 323801776.33B | 0 | |
ROE | -0.09 | -0.14 | -0.09 | -0.08 | -0.06 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
NFX.L Frequently Asked Questions
What is Nuformix plc stock symbol ?
Nuformix plc is a GB stock and trading under the symbol NFX.L
What is Nuformix plc stock quote today ?
Nuformix plc stock price is $0.188 today.
Is Nuformix plc stock public?
Yes, Nuformix plc is a publicly traded company.